Browsing Tag
Ziltivekimab
2 posts
Novo Nordisk’s $2.1bn Corvidia bet faces impairment after ZEUS trial miss
Ziltivekimab’s Phase 3 failure sends Novo Nordisk down 9%, triggers a Corvidia impairment and weakens its cardiovascular expansion strategy.
Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from…